Immuneering (IMRX) Change in Acquisitions & Divestments (2022 - 2026)

Immuneering's Change in Acquisitions & Divestments history runs 4 years deep, the most recent figure standing at $9.0 million for Q1 2026.

• In Q1 2026, Change in Acquisitions & Divestments changed N/A year-over-year to $9.0 million; the TTM figure through Mar 2026 stood at $9.0 million (down 14.29% YoY), while the FY2024 annual figure was $31.9 million, down 38.95% from the prior year.
• Change in Acquisitions & Divestments for Q1 2026 stood at $9.0 million, up from $5.5 million in the prior quarter.
• The five-year high for Change in Acquisitions & Divestments was $32.3 million in Q2 2022, with the low at $5.0 million in Q3 2023.
• The 4-year median for Change in Acquisitions & Divestments is $19.0 million (2023), against an average of $15.5 million.
• The sharpest annual moves came in 2023 and 2024: Change in Acquisitions & Divestments plunged 74.03% in 2023, then gained 12.79% in 2024.
• Immuneering's Change in Acquisitions & Divestments stood at $20.6 million in 2022, then retreated by 7.52% to $19.0 million in 2023, then plunged by 71.13% to $5.5 million in 2024, then jumped by 63.64% to $9.0 million in 2026.
• Business Quant data shows IMRX's Change in Acquisitions & Divestments at $9.0 million in Q1 2026, $5.5 million in Q4 2024, and $5.0 million in Q2 2024.